You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

478 Results
Document
Dec 2020
Document
Jan 2021
Document
Jan 2021
Document
Feb 2021
Document
Feb 2021
Regimen
Cancer Type:
Gynecologic, 
Endometrial
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Advanced or Recurrent Endometrial Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024
Drug
Other Name(s): Tukysa™
Quick Link(s): Drug Monograph, Patient Info Sheet
Feb 2025
Document
May 2021
Guidelines and Advice
Status: Current
ID: GL 2-30B
May 2021

Pages